I have a couple of questions, going back to your annual report in 2016, before they brought the new strategic plan forward. Your annual report indicated that you had identified four risks relating to the increased funding coming in and that sort of thing. Of course, there are risks with that, I guess. You've identified four of them.
One of them was the inability to demonstrate results. Can you just explain that? I think this is important. What have you done to alleviate that risk, and how do you mitigate it? Maybe my colleague Mr. Van Loan mentioned one of them earlier. What other areas can you—?